Price is syncing
Reported smart-money activity is still available below.
1 month
-0.2%
price return
Year to date
+1.6%
price return
Recent earnings
3/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
28 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage is bullish
18 bullish · 7 neutral · 3 bearish
Tone of tracked coverage
Arrowhead Pharmaceuticals, Inc. Revenue Breakdown – BX:HDP1
NeutralJul 26Arrowhead Pharmaceuticals, Inc. Revenue Breakdown – XETR:HDP1
BullishJul 25Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?
Leans bullishJul 23Arrowhead Pharmaceuticals (ARWR) Hits 52-Week High Following Pos
BullishJul 23Arrowhead Pharmaceuticals Inc Stock (ARWR) Closed Up by 19.04% on Jul 22: What Signal Does It Send?
NeutralJul 22Arrowhead Drug Shows Strong Efficacy In Cutting Blood Fat
BullishJul 22Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
BullishJul 22Arrowhead Pharmaceuticals (ARWR) Stock Looks Fairly Priced With Strong Sales But A Demanding 398% Run
NeutralJul 22Q1 2026 13F
$39.4M
position
AlphaYou
